Capital Medica Ventures Releases 'Healthcare New Frontier Fund 2025 Impact Report'
Capital Medica Ventures has published its 8th annual Impact Report for the 'Healthcare New Frontier Fund,' highlighting its contribution to Japan's super-aging society, its reach to 1.91 million beneficiaries, and its recognition by international organizations like GIIN.
📋 Article Processing Timeline
- 📰 Published: April 23, 2026 at 20:00
- 🔍 Collected: April 23, 2026 at 11:31
- 🤖 AI Analyzed: April 24, 2026 at 01:07 (13h 35m after Collected)
Capital Medica Ventures Co., Ltd. (Chiyoda-ku, Tokyo; CEO: Takeshi Aoki) has released the 'Healthcare New Frontier Fund 2025 Impact Report.' This marks the 8th consecutive year of publication since the report's inception in 2019.
The Healthcare New Frontier Fund is a venture capital (VC) fund aimed at addressing Japan's super-aging society by investing in healthcare startups to achieve both social issue resolution and industrial creation. It was established as part of the 'Healthcare New Frontier Policy' promoted by Kanagawa Prefecture and is managed by Capital Medica Ventures. Over eight years of operation, the cumulative number of end-beneficiaries reached through the business activities of portfolio companies has reached 1.91 million.
Started during the early days of impact investing in Japan, the fund has accumulated pioneering initiatives such as developing the 'Issue Design Map' to visualize the structure of the elderly care field, practicing 'Responsible Exits,' and 'Impact IPOs.'
The Impact Report aims to report on the status of impact creation by the fund and its portfolio companies each year. It also aims to promote the practice and spread of impact investing by sharing specific examples with impact investment practitioners and startups practicing impact-oriented business.
This edition features a special section titled 'Practice of Impact Investment and its External Ripple Effects,' summarizing how the fund's initiatives over the past eight years have been evaluated by domestic and international specialized organizations.
- Published the 2nd Disclosure Statement 2024 based on the international Operating Principles for Impact Management (OPIM).
- The Global Impact Investing Network (GIIN) featured the fund's 'Responsible Exit' initiatives as a good practice in 'Common & Emerging Practices in Implementation of the Impact Principles: Principle 7 Impact at EXIT.'
- The fund's Impact IPO case was featured in the book 'Purposeful Finance: Everything About Impact Finance' (Supervised by Tsuyoshi Mizuguchi, Published June 2, 2025).
Capital Medica Ventures will continue to work toward the creation of impact together with its portfolio companies and stakeholders.
[About Capital Medica Ventures Co., Ltd.]
Founded: November 11, 2016
Representative: CEO Takeshi Aoki
Location: 19F Kasumigaseki Building, 3-2-5 Kasumigaseki, Chiyoda-ku, Tokyo
Business: Venture Capital
Capital: 100 million yen
URL: https://capitalmedicaventures.com/
Mission: 'Contribute to solving social problems by excelling as a partner for entrepreneurs.'